READYCELL KITS APPLICATIONS
In Vitro Cytotoxicity Assays
Identifying potential toxicity at early research stages allows to optimize new compounds development.
Cell-based assays with high flexibility.
Full cell functionality after transportation.
Validation data available and high-quality control standards.
ReadyCell CYTOTOXICITY Plates
Advancing cell toxicity evaluation with ready-to-use cell-based plates.
CacoReady 96 Transwell
Measure and stratify the cellular toxicity of your new molecular entity by studying TEER resistance and LY Paracellular Flux.
CacoReady 96 Multiwell
Test your compound in terms of cell viability using classical colorimetric techniques.
Say goodbye to outdated colorimetric assays!
Our new application notes on CacoReady plates will show you how to accurately predict and stratify intestinal toxicity using cutting-edge methods like TEER and LY paracellular flux.
Download for free the latest protocol for acute toxicity assessment.
CELL TOXICITY ASSAY
Ensure the safety of your new molecule
Drug-induced gastrointestinal reactions are one of the main causes of post-market drug withdrawal. These adverse effects can potentially be predicted by in vitro assays, since these side effects, such as diarrhea, correlate with intestinal barrier dysfunction. In this regard, the most commonly used models for intestinal drug studies in pharmaceutical research consist of human intestinal epithelial cells, such as the colon adenocarcinoma cell line Caco-2.
Read more
Caco-2 cells have been extensively used over the last thirty years to study drug absorption across the human intestinal mucosa. The cells are seeded at a very specific cell number and differentiated for 21-days on transwell plates containing a permeable membrane support which results in apical and basal compartments, which artificially simulate the intestinal absorption into the bloodstream.
Caco-2 cells are considered an in vitro gold standard for assessing oral drug absorption. This model provides reliable predictive permeability data either by passive diffusion and/or active transport for hydrophilic to moderately lipophilic compounds and can easily be adapted for high-throughput screening purposes.
The Caco-2 model is also useful to assay active transport of drugs in the central nervous system (CNS) since it expresses two efflux transporters that play a relevant role in the permeation of compounds across the blood brain barrier (BBB).
CYTOTOXICITY PROTOCOL
Cell toxicity testing and stratification in transwell plates
READYCELL Support
Frequently Asked Questions
Is the quality control data specific for each kit?
Yes, we provide a concrete quality control for each batch so the customer can have a reference for the kit before and after shipment.
Does ReadyCell shipping medium affect cell lines?
No, ReadyCell’s Shipping Medium consists of a semi-solid culture system specifically designed to preserve cells at room temperature (15-25ºC). This medium maintains a suitable physicochemical environment, keeping adequate moisture conditions for cellular homeostasis and forming a protective cushion that protects cell integrity and functionality during long-distance shipments up to seven days.
Is it possible to add a testing service to the order?
As a general rule, we act as a supplier and do not provide testing services. Nonetheless, feel free to contact us if you wish to test our plates externally. We can direct you to our partners who can assist you in conducting the assay effectively. Additionally, in certain situations, we are open to collaborating to try out new applications of interest to both of us.
What are the differences between transwell, no-transwell and individual transwell?
The integrated Transwell format is recommended for permeability assays by reference, since it enableds an apical-basal polarization. The non-Transwell format is used for other types of tests, including toxicity or cell culture for measurement of protein expression. The individual Transwell is recommended for permeability tests which require the individual mobility of each Transwell for different times or measurements.
What do the current regulations establish on the basis of cell toxicity tests?
According to the European and the American Regulatory Agencies (EMA and FDA), permeability assays employing cultured Caco-2 are the reference model to estimate intestinal drug absorption in humans.
Which are the main reference compounds for CacoReady and what are the differences between them?
The reference compounds used in these tests are categorized as high permeability, low permeability and P-gp substrate. In the case of CacoReady, the main reference high permeability compound is metoprolol (Papp A-B >10 cm/s) and for the low, atenolol (Papp A-B <0.5 cm/s). Digoxin is used as P-gp substrate with a Papp A-B <1 cm/s.
Related news
Why evaluate MDR1 receptor affinity in CNS pharmacokinetic assays?
MDCKII cells based in vitro system is a recommended model to evaluate blood-brain barrier permeability during CNS action novel compounds.
Toxicological evaluation of chemicals and the implications of human P-gp and BCRP transporters
Publications have confirmed the importance of developing safe chemical agents using membrane transporter analysis as a criterion. This is reflected in the field of pesticides, one of the areas in which this analysis has been most widely applied.
Caco-2 based in vitro models for the screening of anti-inflammatory drugs
Inflammatory reactions of the intestinal tract are the result of a combination of hereditary, genetic and/or environmental factors that have been clustered in the inflammatory bowel disease (IBD). ReadyCell has available CacoReady and CacoGoblet to assay compounds inflammatory properties.
